NOXA genetic amplification or pharmacologic induction primes lymphoma cells to BCL2 inhibitor-induced cell death

Although diffuse large B cell lymphoma (DLBCL) cells widely express the BCL2 protein, they rarely respond to treatment with BCL2-selective inhibitors. Here we show that DLBCL cells harboring PMAIP1/NOXA gene amplification were highly sensitive to BCL2 small-molecule inhibitors. In these cells, BCL2...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Yuxuan, Mondello, Patrizia, Erazo, Tatiana, Tannan, Neeta Bala, Asgari, Zahra, de Stanchina, Elisa, Nanjangud, Gouri, Seshan, Venkatraman E., Wang, Shenqiu, Wendel, Hans-Guido, Younes, Anas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: National Academy of Sciences 2018
Materias:
Biological Sciences
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6255185/
https://www.ncbi.nlm.nih.gov/pubmed/30404918
http://dx.doi.org/10.1073/pnas.1806928115

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6255185/
https://www.ncbi.nlm.nih.gov/pubmed/30404918
http://dx.doi.org/10.1073/pnas.1806928115

Ejemplares similares